NMIBC Market Drivers

Aug 26, 2024

The BCG vaccine, a significant medical breakthrough developed in the early 20th century, is derived from a strain of Mycobacterium bovis initially created by the University of Illinois as a vaccine against tuberculosis. For NMIBC, BCG is administered intravesically to reduce the risk of cancer recurrence and progre...

Oct 12, 2020

After 40 years of the introduction of the BCG immunotherapy, it continues to remain as the gold standard of the treatment of Non-muscle invasive bladder cancer (NMIBC). However, BCG intravesical therapy fails to yield responses in more than 50% of the NMIBC patients. After a shocking failure of BCG, cystectomy is p...